Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
13 June 2024 | Story Edzani Nephalela | Photo Supplied
Dr Nomalungelo Ngubane
Dr Nomalungelo Ngubane, the Director of the Academy for Multilingualism, is at the forefront of this initiative, championing diversity and inclusiveness for all stakeholders at the University of the Free State.

Diversity in higher education institutions enriches the learning environment, fostering a culture of inclusion and mutual respect. It broadens perspectives, encourages critical thinking, and prepares students for a global workforce by supporting equitable access to opportunities and enhancing all students' personal growth and academic excellence.

The University of the Free State (UFS) has marked a significant milestone in its commitment to linguistic diversity with the official translation of its Language Policy into three additional languages: Sesotho, Afrikaans, and isiZulu. Previously only available in English, the translation of the policy – approved by the University Council in November 2023 – into these languages reflects the university's dedication to inclusivity and recognition of its diverse community.

The collaboration between the Academy for Multilingualism and the Institutional Regulatory Code was instrumental in a groundbreaking initiative: making the Language Policy accessible to speakers of African languages. Spearheaded by the Academy for Multilingualism, this endeavour involved a thorough translation, formatting, and proofreading process.

Dr Nomalungelo Ngubane, Director of the Academy for Multilingualism, emphasised that the availability of the Language Policy in multiple languages is not merely symbolic, but underscores the UFS' values of respect, human dignity, and social justice, as outlined in its Vision130. “This initiative aligns with the university's overarching goal of fostering an environment where all languages are valued and respected. We also hope that the Language Policy will not just be written in different languages but will strengthen the implementation of the policy in various domains of the university to achieve its objectives.

She further explains that the translation project is expected to have far-reaching impacts on how policies are communicated and understood within the university, because it enhances the ability of students, staff, and stakeholders to participate more fully in university life, contributing to a more cohesive and integrated community.

This initiative is a testament to the UFS' commitment to embracing and celebrating linguistic diversity as a fundamental aspect of its identity and operations.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept